If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Feb 2024 07:00

RNS Number : 8380D
KRM22 PLC
21 February 2024
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today announces the following trading update.

 

The Company is executing on its plan to increase the value of its Annual Recurring Revenue ("ARR") to £10m through the development of new products, leveraging the distribution reach of key partners and realising new business from a growing pipeline of new prospects. 

 

At the date of this announcement, the Company's ARR stands at £5.8m (£4.6m at 31 December 2022). The continued growth in ARR has come from a revived product suite including multi-year contracts for Risk Manager, Limits Manager and Market Surveillance via direct sales and sales from distributors including Trading Technologies International, Inc. ("TT") under the terms of the distribution agreement with TT signed in December 2021.

 

The underlying cost base of the business continues to be tightly managed and, following a careful review by the Board, management have taken a decision to implement a focused cost saving program with annual cost savings of approximately £1.2m early in the current financial year. The cost savings are expected to accelerate the Company's path to profitability, whilst having minimal impact on operations as the savings have come from staff redundancies in roles where operational synergies can be achieved and a reduction in contracted development resources as specific projects are nearing completion.

 

The growth in ARR, together with the continued management of the underlying cost base of the business and the availability of funds to drawdown from the TT debt facility means that the Company expects to operate within its existing available cash and facilities and anticipated new contract signings.

 

The Company expects to report audited results for the 12-month period to 31 December 2023 ("FY2023") in May 2024, and the financial highlights* include:

 

· Gross cash as of 31 December 2023 of £0.9m (FY2022: £1.9m)

· ARR of 31 December 2023 of £5.4m (FY2022: £4.6m at constant FX rates) - growth of 17.4%

New contracted ARR in the year of £1.1m (FY2022: £1.3m)

· Total revenue recognised of approximately £5.2m (FY2022: £4.3m) - growth of 20.9%

· Net debt at 31 December 2023 of £3.6m with the Company having drawn down a total of £4.5m on the debt facility with TT announced on 19 June 2023 with £0.5m remaining undrawn.

 

Stephen Casner, CEO at KRM22 commented: "Our continued growth reflects the persistent demand that the derivatives market has for KRM22's next generation of risk management systems. In the last few months we have added three new FCMs, including one top 10 FCM, to KRM22's risk platform. Our pipeline of new sales opportunities remains strong and we expect further announcements detailing additional FCM's committing to our Limits Manager product in H1 2024. The Company expects current cash and the debt facility to provide sufficient runway to a cash flow positive position and is looking to resume market forecasts upon release of audited financials in May 2024."

 

\* The financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes.

 

 

For further information please contact:

 

KRM22 plc

Keith Todd CBE, Executive Chairman

Stephen Casner, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Carl Holmes / George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELEFSELSEIE
Date   Source Headline
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSIssue of Options
12th Jan 20217:00 amRNSTrading Update
5th Oct 20207:00 amRNSIssue of Options
21st Sep 20208:33 amRNSIssue of Options
18th Sep 20209:26 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSNew Debt Facility
16th Sep 20207:00 amRNSInterim Results
17th Aug 20207:00 amRNSNew Customer Contract
23rd Jul 202010:49 amRNSIssue of Options
21st Jul 20207:00 amRNSTrading Update
3rd Jul 20201:37 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSConversion of Convertible Loan Note
25th Jun 202011:51 amRNSResult of AGM
2nd Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20207:00 amRNSSubscription
21st May 20207:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31 DEC 2019
20th May 20204:41 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHolding(s) in Company
18th May 20208:53 amRNSHolding(s) in Company
14th May 20207:00 amRNSCompletion of Equity Fundraising
11th May 20207:00 amRNSUpdate on Equity Fundraising
7th May 20202:47 pmRNSStatement re. share price movement
17th Apr 20207:00 amRNSConsolidation of ownership of Irisium Ltd
2nd Apr 20207:00 amRNSDirectorate Changes
2nd Apr 20207:00 amRNSTrading Update
13th Jan 20204:30 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSTrading Update
3rd Dec 20197:00 amRNSDirectorate Changes
20th Nov 20198:03 amRNSKRM22 announces Market Risk solution for the GRP
14th Nov 20195:23 pmRNSHolding(s) in Company
7th Nov 20197:01 amRNSKRM22 announces partnership with deltaconX
7th Nov 20197:00 amRNSPlacing
31st Oct 20197:00 amRNSBusiness Update
3rd Oct 20197:00 amRNSNew customer contract
24th Sep 20194:40 pmRNSSecond Price Monitoring Extn
24th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20197:00 amRNSKRM22 adds Digital Client Onboarding to offering
11th Jul 20197:00 amRNSPartnership with Quant Foundry
11th Jul 20197:00 amRNSHalf Year Trading Update
28th Jun 201911:52 amRNSResult of AGM
25th Jun 201910:17 amRNSHolding(s) in Company
19th Jun 20197:00 amRNSPartnership with Neotas
6th Jun 20199:00 amRNSNotice of AGM & Posting of Annual Report
6th Jun 20197:00 amRNSSubscription
5th Jun 20196:13 pmRNSHolding(s) in Company
3rd Jun 20197:01 amRNSDirector role change
3rd Jun 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.